How do you think we find new therapeutic options? Even with CHOP, it was by trial and error with a similar starting point. While animal data is needed, many reputable journals are showing encouraging positive effects when used on cancers at low, non-toxic doses. Besides, in cases where CHOP has not worked, a low non-toxic does of Ivermectin holds low risk when no other options exist when balanced against the research.